Skip Nav Destination
Article navigation
Meeting Abstracts|
September 2000
Room 224-226, 10/16/2000 9: 00 AM - 10: 30 AM (PD) Early Antagonism of Neuromuscular Block: Is It Effective? : A-1039
Dept of Anesthesiology, Weill Medical College of Cornell University, New York, NY, United States.
Anesthesiology September 2000, Vol. 93, A–1039.
Citation
Cynthia A. Lien, Matthew R. Belmont, John J. Savarese; Room 224-226, 10/16/2000 9: 00 AM - 10: 30 AM (PD) Early Antagonism of Neuromuscular Block: Is It Effective? : A-1039. Anesthesiology 2000; 93:A–1039 doi: https://doi.org/10.1097/00000542-200009001-01039
Download citation file:
145
Views
Citing articles via
Most Viewed
Related Articles
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine—Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat
Anesthesiology (October 2016)
Rapid Chemical Antagonism of Neuromuscular Blockade by l-Cysteine Adduction to and Inactivation of the Olefinic (Double-bonded) Isoquinolinium Diester Compounds Gantacurium (AV430A), CW 002, and CW 011
Anesthesiology (July 2010)
Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine
Anesthesiology (November 2018)
Antagonism of Residual Mivacurium Blockade: Setting the Record Straight
Anesthesiology (June 1996)